FLT4
FLT4 |
|
|
Identifiers |
Aliases |
FLT4, FLT41, LMPH1A, PCL, VEGFR3, FLT-4, VEGFR-3, fms related tyrosine kinase 4 |
External IDs |
MGI: 95561 HomoloGene: 7321 GeneCards: FLT4 |
|
Targeted by Drug |
cediranib, lenvatinib, linifanib, motesanib, nintedanib, pazopanib, sunitinib, tivozanib, vatalanib
|
|
Orthologs |
Species |
Human |
Mouse |
Entrez |
|
|
Ensembl |
|
|
UniProt |
|
|
RefSeq (mRNA) |
|
|
RefSeq (protein) |
|
|
Location (UCSC) |
Chr 5: 180.6 – 180.65 Mb |
Chr 11: 49.61 – 49.65 Mb |
PubMed search |
|
|
|
|
|
4BSJ, 4BSK
2324
14257
ENSG00000037280
ENSMUSG00000020357
P35916
P35917
NM_002020
NM_182925
NM_008029
NP_002011
NP_891555
NP_032055.1
NP_032055
Fms-related tyrosine kinase 4, also known as FLT4, is a protein which in humans is encoded by the FLT4 gene.
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.
...
Wikipedia